Andrew N. Antoszyk
About
In The Last Decade
Andrew N. Antoszyk
52 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Ophthalmology 3.1k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Molecular Biology 414
- Biomedical Engineering 183
- Epidemiology 139
Countries citing papers authored by Andrew N. Antoszyk
This map shows the geographic impact of Andrew N. Antoszyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew N. Antoszyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew N. Antoszyk more than expected).
Fields of papers citing papers by Andrew N. Antoszyk
This network shows the impact of papers produced by Andrew N. Antoszyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew N. Antoszyk. The network helps show where Andrew N. Antoszyk may publish in the future.
Co-authorship network of co-authors of Andrew N. Antoszyk
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew N. Antoszyk. A scholar is included among the top collaborators of Andrew N. Antoszyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew N. Antoszyk. Andrew N. Antoszyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Initial Aflibercept Versus Vitrectomy with Panretinal Photocoagulation for Vitreous Hemorrhage (VH) From Proliferative Diabetic Retinopathy (PDR): A DRCR Retina Network Randomized Clinical Trial | 1 |
| 2 | 45 | |
| 3 | Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy breakdown → | 262 |
| 4 | 4 | |
| 5 | Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy breakdown → | 529 |
| 6 | 63 | |
| 7 | Erbium:YAG Laser Scalpel with Novel Microsphere Chain Fiber Optic Tip for More Precise Vitreoretinal Surgery | 1 |
| 8 | 295 | |
| 9 | Efficacy and Safety of ILUVIEN® (Fluocinolone Acetonide [FAc] Intravitreal Insert) for the Treatment of Diabetic Macular Edema | 3 |
| 10 | 64 | |
| 11 | 38 | |
| 12 | 32 | |
| 13 | 32 | |
| 14 | 36 | |
| 15 | 337 | |
| 16 | 49 | |
| 17 | 308 | |
| 18 | 85 | |
| 19 | 39 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.